Toronto-listed Aurora Cannabis and Canopy Growth also contributed to Monday's decline, sliding 12.2 percent and 11.2 percent, respectively. Aurora also started trading in the U.S. on Tuesday, dropping 14 percent in its NYSE debut.
Traders blamed several reasons for the sell-off in the big cannabis names. Several large conferences in the past few weeks, as well as legalization in Canada on Oct. 17, generated excitement in the space and bid up prices, one Canopy Growth shareholder told CNBC. Monday's move may reflect a degree of profit-taking, investors said.
Bennett Gross, president and manager at Los Angeles-based L&S Advisors, said he's not focused on intraday action and remains excited to be a part of an industry he expects to flourish over the next several years.
"It's about owning a piece of an industry that'll be much bigger in five to 10 years. ... We really like the financial strength of Canopy in terms of having a large war chest," Gross said, noting the cannabis producer's relationship with Constellation Brands.
"Prohibition ends only once, and this industry could be worth tens of billions of dollars," he added. "I think picking who the winners will be is virtually impossible. We're happy owning a more established company."
Investors could also be raising cash before the launch of three big U.S.-based cannabis companies on Canadian stock exchanges within the next month, the trader said.
Acreage Holdings, one of the U.S.' largest vertically integrated multistate cannabis operators, announced earlier this year that it had closed a Series E funding round, securing $119 million of capital. The company is expected to launch on the Canadian Stock Exchange in early November.
WATCH:The cannabis sativa plant isn't just for smoking. You can build your home with hemp